» Articles » PMID: 31683582

Nanotechnology in Oral Cavity Carcinoma: Recent Trends and Treatment Opportunities

Overview
Date 2019 Nov 6
PMID 31683582
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Oral cavity carcinoma (OCC) remains an ongoing public health problem. Emerging nanotechnology provides alternative treatment approaches. This review covers the up-to-date literature in the human OCC treatment field. We explored the growing body of evidence to reveal novel and highly promising diagnostic and therapeutic applications of nanotechnology in this field. Various types of nanoparticles have been tested for applications in OCC. Imaging modalities in addition to nanocarriers are discussed. The encouraging contribution of lymphotropic nanoparticles contrast in the diagnosis of metastatic cervical lymph nodes needs to be confirmed. The development of the sentinel lymph node procedure and photodynamic therapy may lead to breakthrough therapies in order improve clinical outcomes and quality of life. In this perspective, cancer nanotechnology has the potential to revolutionize the treatment of OCC patients.

Citing Articles

Lymph nodes in oral squamous cell carcinoma: a comprehensive anatomical perspective.

Wang G, Zhong N, Cao L, Liu X, Li Z, Xiao Y Clin Exp Metastasis. 2024; 41(6):877-890.

PMID: 39377834 DOI: 10.1007/s10585-024-10317-y.


Nano-Drug Carriers for Targeted Therapeutic Approaches in Oral Cancer: A Systematic Review.

Kattimani V, Bhukya N, Panga G, Chakrabarty A, Lingamaneni P J Maxillofac Oral Surg. 2024; 23(4):763-771.

PMID: 39118900 PMC: 11303611. DOI: 10.1007/s12663-024-02251-z.


Nanoparticles as drug delivery systems in the treatment of oral squamous cell carcinoma: current status and recent progression.

Cui S, Liu H, Cui G Front Pharmacol. 2023; 14:1176422.

PMID: 37292147 PMC: 10244499. DOI: 10.3389/fphar.2023.1176422.


Postoperative Delirium in Patients with Oral Cancer: Is Intraoperative Fluid Administration a Neglected Risk Factor?.

Obermeier K, Kraus M, Smolka W, Henkel J, Saller T, Otto S Cancers (Basel). 2022; 14(13).

PMID: 35804948 PMC: 9265071. DOI: 10.3390/cancers14133176.


Mucoadhesive Nanocarriers as a Promising Strategy to Enhance Intracellular Delivery against Oral Cavity Carcinoma.

Pandey M, Choudhury H, Ying J, Ling J, Ting J, Ting J Pharmaceutics. 2022; 14(4).

PMID: 35456629 PMC: 9025168. DOI: 10.3390/pharmaceutics14040795.

References
1.
Liu M, Wang S, Yang X, Peng H . Diagnostic Efficacy of Sentinel Lymph Node Biopsy in Early Oral Squamous Cell Carcinoma: A Meta-Analysis of 66 Studies. PLoS One. 2017; 12(1):e0170322. PMC: 5249063. DOI: 10.1371/journal.pone.0170322. View

2.
Curvo-Semedo L, Diniz M, Migueis J, Juliao M, Martins P, Pinto A . USPIO-enhanced magnetic resonance imaging for nodal staging in patients with head and neck cancer. J Magn Reson Imaging. 2006; 24(1):123-31. DOI: 10.1002/jmri.20602. View

3.
Chone C, Aniteli M, Magalhaes R, Freitas L, Altemani A, Ramos C . Impact of immunohistochemistry in sentinel lymph node biopsy in head and neck cancer. Eur Arch Otorhinolaryngol. 2012; 270(1):313-7. DOI: 10.1007/s00405-012-2032-5. View

4.
van der Poel H, Buckle T, Brouwer O, Olmos R, van Leeuwen F . Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol. 2011; 60(4):826-33. DOI: 10.1016/j.eururo.2011.03.024. View

5.
Molstrom J, Gronne M, Green A, Bakholdt V, Sorensen J . Topographical distribution of sentinel nodes and metastases from T1-T2 oral squamous cell carcinomas. Eur J Cancer. 2018; 107:86-92. DOI: 10.1016/j.ejca.2018.10.021. View